nach oben

World Journal of Urology

Erschienen in:

01.06.2013 | Topic Paper

Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes

verfasst von: Stephen B. Williams, Jim C. Hu

Erschienen in: World Journal of Urology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Salvage robotic assisted laparoscopic radical prostatectomy (SRALP) has now become a feasible alternative to open prostatectomy in experienced hands. Herein we review the urologic literature for the indications and outcomes of SRALP.

Methods

A comprehensive review of the peer reviewed literature was performed for reported cases of salvage robotic and open prostatectomy, with emphasis being on comparing oncologic outcomes.

Results

Salvage prostatectomy, whether open or robotic, is a viable alternative for treatment of recurrent, localized, non-metastatic prostate cancer after failed primary radiotherapy. Although few reports of salvage robotic prostatectomy have been published with limited long-term follow-up, initial oncologic results seem at least comparable to the salvage open prostatectomy series. SRALP should be performed by centers with a dedicated and well experienced robotic urologic oncology program.

Conclusions

SRALP is a feasible surgical treatment option for patients with recurrence after primary radiotherapy with preliminary oncologic outcomes comparable to the open approach. Further long-term follow-up is needed to validate these results.

Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249PubMedCrossRef

D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974PubMedCrossRef

Agarwal PK, Sadetsky N, Konety BR et al (2008) Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 112:307–314PubMedCrossRef

Bianco FJ Jr, Scardino PT, Stephenson AJ et al (2005) Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62:448–453PubMedCrossRef

Stephenson AJ, Eastham JA (2005) Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol 23:8198–8203PubMedCrossRef

Touma NJ, Izawa JI, Chin JL (2005) Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 173:373–379PubMedCrossRef

Ward JF, Sebo TJ, Blute ML et al (2005) Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 173:1156–1160PubMedCrossRef

Sanderson KM, Penson DF, Cai J et al (2006) Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 176:2025–2031; discussion 2031–2032

Vaidya A, Soloway MS (2000) Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. J Urol 164:1998–2001PubMedCrossRef

10.

Lerner SE, Blute ML, Zincke H (1995) Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol 154:1103–1109PubMedCrossRef

11.

Grossfeld GD, Li YP, Lubeck DP et al (2002) Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 168:530–535PubMedCrossRef

12.

Keating NL, O’Malley AJ, Smith MR (2006) Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24:4448–4456PubMedCrossRef

13.

Van Hemelrijck M, Adolfsson J, Garmo H et al (2010) Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol 11:450–458PubMedCrossRef

14.

Rogers E, Ohori M, Kassabian VS et al (1995) Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 153:104–110PubMedCrossRef

15.

Hu JC, Gu X, Lipsitz SR et al (2009) Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 302:1557–1564PubMedCrossRef

16.

Hu JC, Wang Q, Pashos CL et al (2008) Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol 26:2278–2284PubMedCrossRef

17.

Tewari A, Srivasatava A, Menon M (2003) A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution. BJU Int 92:205–210PubMedCrossRef

18.

Ahlering TE (2004) Robotic versus laparoscopic radical prostatectomy. Nat Clin Pract Urol 1:58–59PubMedCrossRef

19.

Menon M, Shrivastava A, Kaul S et al (2007) Vattikuti Institute prostatectomy: contemporary technique and analysis of results. Eur Urol 51:648–657; discussion 657–658

20.

Jamal K, Challacombe B, Elhage O et al (2008) Successful salvage robotic-assisted radical prostatectomy after external beam radiotherapy failure. Urology 72:1356–1358PubMedCrossRef

21.

Boris RS, Bhandari A, Krane LS et al (2009) Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes. BJU Int 103:952–956PubMedCrossRef

22.

Eandi JA, Link BA, Nelson RA et al (2010) Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer. J Urol 183:133–137PubMedCrossRef

23.

Kaouk JH, Hafron J, Goel R et al (2008) Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results. BJU Int 102:93–96PubMedCrossRef

24.

Kuban DA, Thames HD, Levy LB et al (2003) Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57:915–928PubMedCrossRef

25.

Consensus statement: guidelines for PSA following radiation therapy (1997) American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37:1035–1041

26.

Roach M III, Hanks G, Thames H Jr et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965–974PubMedCrossRef

27.

Cher ML, Bianco FJ Jr, Lam JS et al (1998) Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol 160:1387–1391PubMedCrossRef

28.

Sala E, Eberhardt SC, Akin O et al (2006) Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 238:176–183PubMedCrossRef

29.

Sella T, Schwartz LH, Swindle PW et al (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231:379–385PubMedCrossRef

30.

Kane CJ, Amling CL, Johnstone PA et al (2003) Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology 61:607–611PubMedCrossRef

31.

Beresford MJ, Gillatt D, Benson RJ et al (2010) A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence. Clin Oncol (R Coll Radiol) 22:46–55CrossRef

32.

Crook J, Malone S, Perry G et al (2000) Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 48:355–367PubMedCrossRef

33.

Bostwick DG, Egbert BM, Fajardo LF (1982) Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol 6:541–551PubMedCrossRef

34.

Crook JM, Malone S, Perry G et al (2009) Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial. Cancer 115:673–679PubMedCrossRef

35.

Zelefsky MJ, Ben-Porat L, Scher HI et al (2005) Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. J Clin Oncol 23:826–831PubMedCrossRef

36.

Zagars GK, Pollack A, von Eschenbach AC (1995) Prostate cancer and radiation therapy—the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 33:23–35PubMedCrossRef

37.

Ward JF, Pagliaro LC, Pisters LL (2008) Salvage therapy for radiorecurrent prostate cancer. Curr Probl Cancer 32:242–271PubMedCrossRef

38.

Paparel P, Cronin AM, Savage C et al (2009) Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Eur Urol 55:404–410PubMedCrossRef

39.

Kimura M, Mouraviev V, Tsivian M et al (2010) Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int 105:191–201PubMedCrossRef

40.

Masterson TA, Stephenson AJ, Scardino PT et al (2005) Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology 66:623–626PubMedCrossRef

Titel: Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes
verfasst von: Stephen B. Williams
Jim C. Hu
Publikationsdatum: 01.06.2013
Verlag: Springer-Verlag
Erschienen in: World Journal of Urology / Ausgabe 3/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-010-0619-2

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes

Abstract

Objectives

Methods

Results

Conclusions

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Dismembered and non-dismembered retroperitoneoscopic pyeloplasty for the treatment of ureteropelvic junction obstruction in children

Long-term oncological and functional results of extraperitoneal laparoscopic radical prostatectomy: one surgical team’s experience on 1,600 consecutive cases

Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses

Methicillin-resistant Staphylococcus aureus (MRSA) in an Austrian urological department: 10 years experience covering 95.161 patients

Macroscopic and microsurgical varicocelectomy: what’s the intraoperative difference?

Robotic-assisted laparoscopic radical cystectomy: history, techniques and outcomes

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie